<h1>PIL seeks nationwide inquiry and systemic reforms after child deaths allegedly linked to toxic cough syrups, central probe</h1> The Supreme Court agreed to hear a public interest litigation seeking a court-monitored, nationwide inquiry and systemic reform in drug safety after child deaths allegedly linked to toxic cough syrups. The PIL requests transfer of all pending FIRs and investigations to the central investigative agency, formation of a national expert commission headed by a retired apex-court judge to oversee uniform probes, identification of regulatory failures that permitted substandard medicines into the market, and mandatory toxicological testing of suspect products in NABL-accredited laboratories before further sale or export; the matter is listed for hearing on the specified date.